Ignite Creation Date:
2024-05-05 @ 5:08 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00390390
Status:
COMPLETED
Last Update Posted:
2010-05-25
First Post:
2006-10-18
Brief Title:
EfficacySafety of Lansoprazole in Patients With Frequent Heartburn
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
A Phase III Multi-center Randomized Double-blind Placebo-controlled Parallel Group Trial of 14 Day Treatment With Lansoprazole 15 mg Once a Day in Frequent Heartburn
Status:
COMPLETED
Status Verified Date:
2007-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Heartburn a burning sensation in the chest or throat occurs in many patients when acidic stomach contents move into the esophagus from the stomach This study will investigate the safety and efficacy of lansoprazole 15 mg once a day in treating frequent heartburn
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None